<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02364518</url>
  </required_header>
  <id_info>
    <org_study_id>TranQuill™ Sling Snoreplasty</org_study_id>
    <nct_id>NCT02364518</nct_id>
  </id_info>
  <brief_title>TranQuill™ Sling Snoreplasty for Snoring and Mild Obstructive Sleep Apnea:</brief_title>
  <official_title>TranQuill™ Sling Snoreplasty for Snoring and Mild Obstructive Sleep Apnea: A Single-arm, Pilot Study for Safety and Effectiveness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and effectiveness of TranQuillTM Sling (a&#xD;
      suture or thread used in surgery that is knotless) in snoreplasty (surgery procedure) for the&#xD;
      treatment of snoring and mild OSA in adult subjects. The TranQuill Sling Snoreplasty (QSS) is&#xD;
      a procedure where the suture will be inserted into the soft palate tissues for the treatment&#xD;
      of snoring and/or mild obstructive sleep apnea. Soft palate tissues are tissues in the back&#xD;
      of the roof of the mouth.&#xD;
&#xD;
      The research results will be used to provide data on feasibility (strengths and weaknesses),&#xD;
      safety, performance, and effectiveness data for the Surgical Specialties, Inc as a therapy&#xD;
      for snoring and/or mild obstructive sleep apnea. The TranQuillTM Sling is approved by the&#xD;
      U.S. Food and Drug Administration (FDA). The TranQuillTM Sling is used in all types of&#xD;
      surgery that involved deep tissues in the body.&#xD;
&#xD;
      The investigator in charge of the study is Dr. Boyd Gillespie. MUSC and Dr. Gillespie receive&#xD;
      financial support from Surgical Specialties, Inc. to conduct the study. MUSC is the only&#xD;
      place that this study will be conducted. For this research study the investigators plan to&#xD;
      enroll a total of up to 20 subjects at the Medical University of South Carolina.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Methodology:&#xD;
&#xD;
      Subject Recruitment. Twenty subjects will be recruited from the MUSC Snoring Clinics as well&#xD;
      as public information seminars held in the greater Charleston area. Attempts will be made to&#xD;
      recruit both a gender and racially diverse study population.&#xD;
&#xD;
      Subject Screening. Subjects who are potentially eligible for the trial include patients who&#xD;
      seek treatment chronic snoring disruptive to their bed-partner. Patients will require a&#xD;
      pre-treatment assessment with a Watch-PAT home sleep study device to rule-out moderate and&#xD;
      severe sleep apnea. Patients must have a regular bed-partner to participate in order to&#xD;
      capture study outcomes.&#xD;
&#xD;
      Inclusion Criteria. Potential subjects must meet the following inclusion criteria:&#xD;
&#xD;
        -  Age ≥ 22 years (no upper limit)&#xD;
&#xD;
        -  Regular bed-partner&#xD;
&#xD;
        -  Chronic, disruptive snoring according to bed-partner&#xD;
&#xD;
        -  Snoring, upper airway resistance syndrome, or mild obstructive sleep apnea (AHI ≤ 15;&#xD;
           lowest O2 saturation ≥ 85%) on home sleep testing with Watch-PAT&#xD;
&#xD;
        -  No prior surgical treatment for snoring or OSAS other than nasal surgery&#xD;
&#xD;
        -  Willing and capable of providing informed consent&#xD;
&#xD;
      Exclusion Criteria.&#xD;
&#xD;
        -  Age &lt; 22 years&#xD;
&#xD;
        -  No regular bed-partner&#xD;
&#xD;
        -  Intermittent or occasional snoring&#xD;
&#xD;
        -  Moderate-to-severe obstructive sleep apnea (AHI ≥ 16; Lowest O2 sat &lt;85%) or evidence of&#xD;
           central apnea (≥ 10% of apneic events) on home sleep testing with Watch-PAT&#xD;
&#xD;
        -  BMI ≥ 32 kg/m2&#xD;
&#xD;
        -  Modified Mallampati 3 or 4&#xD;
&#xD;
        -  Tonsil Grade 3 or 4&#xD;
&#xD;
        -  Significant nasal obstruction (&gt; 50% of nasal airway diameter on one side)&#xD;
&#xD;
        -  Previous palatal surgery (cleft palate; uvulopalatopharyngoplasty; uvulectomy; Pillar&#xD;
           implants; Somnoplasty)&#xD;
&#xD;
        -  Current cigarette smoker (≥ 1 cigarette per day)&#xD;
&#xD;
        -  Known history of coronary artery disease or stroke&#xD;
&#xD;
        -  Chronic obstructive pulmonary disease (COPD)&#xD;
&#xD;
        -  Diabetes&#xD;
&#xD;
        -  Major depression or non-controlled psychiatric illness&#xD;
&#xD;
        -  Drug or alcohol abuse&#xD;
&#xD;
        -  Untreated or poorly controlled hypertension&#xD;
&#xD;
        -  Anticoagulation therapy (ex. Coumadin or Plavix; single baby aspirin per day allowable)&#xD;
&#xD;
        -  History of bleeding or clotting disorder&#xD;
&#xD;
        -  Another significant sleep disorder (e.g., insomnia, periodic limb movement)&#xD;
&#xD;
        -  Tonsillar hypertrophy&#xD;
&#xD;
        -  Chronic Obstructive Pulmonary Disease (COPD)&#xD;
&#xD;
        -  Interstitial Lung Disease (ILD)&#xD;
&#xD;
        -  Cystic Fibrosis&#xD;
&#xD;
        -  Acute Repiratory Distress Syndrome (ARDS)&#xD;
&#xD;
        -  Nasal or supraglottic obstruction on fiberoptic examination&#xD;
&#xD;
        -  ASA class III ,IV, V&#xD;
&#xD;
        -  Latex allergy&#xD;
&#xD;
        -  Lidocaine allergy&#xD;
&#xD;
        -  Pregnancy or plans to become pregnant Note: women of childbearing potential must&#xD;
           demonstrate a negative pregnancy test upon enrollment and/or be using an acceptable form&#xD;
           of birth control (OCPs; IUD).&#xD;
&#xD;
        -  Major depression or non-stabilized psychiatric disorder&#xD;
&#xD;
        -  Drug or alcohol abuse&#xD;
&#xD;
        -  Previous palatal or tongue surgery&#xD;
&#xD;
        -  Stable or unstable angina&#xD;
&#xD;
        -  CHF&#xD;
&#xD;
        -  Moderate or severe valvular disease&#xD;
&#xD;
        -  TIA/CVA&#xD;
&#xD;
        -  Carotid stenosis or endarterectomy&#xD;
&#xD;
        -  Anemia&#xD;
&#xD;
        -  Room air SpO2 &lt; 95%&#xD;
&#xD;
        -  Pulmonary hypertension&#xD;
&#xD;
        -  Dialysis&#xD;
&#xD;
        -  Central or mixed apnea ≥ 10% of respiratory events&#xD;
&#xD;
        -  Participation in another clinical study (enrolled in any concurrent study) whose&#xD;
           investigational plan is judged to interfere or affect any of the measures of this study&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>90 days</time_frame>
    <description>0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen Desaturation Index</measure>
    <time_frame>90 days</time_frame>
    <description>0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory Disturbance Index</measure>
    <time_frame>90 days</time_frame>
    <description>0-100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bed Partner Scoring</measure>
    <time_frame>90 days</time_frame>
    <description>0-10</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Snoring</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Snoreplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of Snoring and/or mild obstructive sleep apnea with snoreplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Snoreplasty</intervention_name>
    <description>The procedure will be performed under local anesthesia in the examination chair. The subject's throat will be anesthetized with benzocaine spray followed by infiltration of the soft palate with 4-5 milliliters of 1% lidocaine with 1:100,000 epinephrine. The TranQuill suture will be inserted into the soft palate tissues using a predescribed pattern.</description>
    <arm_group_label>Snoreplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 22 years (no upper limit)&#xD;
&#xD;
          -  Regular bed-partner&#xD;
&#xD;
          -  Chronic, disruptive snoring according to bed-partner&#xD;
&#xD;
          -  Snoring, upper airway resistance syndrome, or mild obstructive sleep apnea (AHI ≤ 15;&#xD;
             lowest O2 saturation ≥ 85%) on home sleep testing with Watch-PAT&#xD;
&#xD;
          -  No prior surgical treatment for snoring or OSAS other than nasal surgery&#xD;
&#xD;
          -  Willing and capable of providing informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 22 years&#xD;
&#xD;
          -  No regular bed-partner&#xD;
&#xD;
          -  Intermittent or occasional snoring&#xD;
&#xD;
          -  Moderate-to-severe obstructive sleep apnea (AHI ≥ 16; Lowest O2 sat &lt;85%) or evidence&#xD;
             of central apnea (≥ 10% of apneic events) on home sleep testing with Watch-PAT&#xD;
&#xD;
          -  BMI ≥ 32 kg/m2&#xD;
&#xD;
          -  Modified Mallampati 3 or 4&#xD;
&#xD;
          -  Tonsil Grade 3 or 4&#xD;
&#xD;
          -  Significant nasal obstruction (&gt; 50% of nasal airway diameter on one side)&#xD;
&#xD;
          -  Previous palatal surgery (cleft palate; uvulopalatopharyngoplasty; uvulectomy; Pillar&#xD;
             implants; Somnoplasty)&#xD;
&#xD;
          -  Current cigarette smoker (≥ 1 cigarette per day)&#xD;
&#xD;
          -  Known history of coronary artery disease or stroke&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease (COPD)&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Major depression or non-controlled psychiatric illness&#xD;
&#xD;
          -  Drug or alcohol abuse&#xD;
&#xD;
          -  Untreated or poorly controlled hypertension&#xD;
&#xD;
          -  Anticoagulation therapy (ex. Coumadin or Plavix; single baby aspirin per day&#xD;
             allowable)&#xD;
&#xD;
          -  History of bleeding or clotting disorder&#xD;
&#xD;
          -  Another significant sleep disorder (e.g., insomnia, periodic limb movement)&#xD;
&#xD;
          -  Tonsillar hypertrophy&#xD;
&#xD;
          -  Chronic Obstructive Pulmonary Disease (COPD)&#xD;
&#xD;
          -  Interstitial Lung Disease (ILD)&#xD;
&#xD;
          -  Cystic Fibrosis&#xD;
&#xD;
          -  Acute Repiratory Distress Syndrome (ARDS)&#xD;
&#xD;
          -  Nasal or supraglottic obstruction on fiberoptic examination&#xD;
&#xD;
          -  ASA class III ,IV, V&#xD;
&#xD;
          -  Latex allergy&#xD;
&#xD;
          -  Lidocaine allergy&#xD;
&#xD;
          -  Pregnancy or plans to become pregnant Note: women of childbearing potential must&#xD;
             demonstrate a negative pregnancy test upon enrollment and/or be using an acceptable&#xD;
             form of birth control (OCPs; IUD).&#xD;
&#xD;
          -  Major depression or non-stabilized psychiatric disorder&#xD;
&#xD;
          -  Drug or alcohol abuse&#xD;
&#xD;
          -  Previous palatal or tongue surgery&#xD;
&#xD;
          -  Stable or unstable angina&#xD;
&#xD;
          -  CHF&#xD;
&#xD;
          -  Moderate or severe valvular disease&#xD;
&#xD;
          -  TIA/CVA&#xD;
&#xD;
          -  Carotid stenosis or endarterectomy&#xD;
&#xD;
          -  Anemia&#xD;
&#xD;
          -  Room air SpO2 &lt; 95%&#xD;
&#xD;
          -  Pulmonary hypertension&#xD;
&#xD;
          -  Dialysis&#xD;
&#xD;
          -  Central or mixed apnea ≥ 10% of respiratory events&#xD;
&#xD;
          -  Participation in another clinical study (enrolled in any concurrent study) whose&#xD;
             investigational plan is judged to interfere or affect any of the measures of this&#xD;
             study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M. Boyd Gillespie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shaun A Nguyen, MD, MA, CPI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Otolaryngology- Head and Neck Surgery- Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>April 15, 2014</study_first_submitted>
  <study_first_submitted_qc>February 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2015</study_first_posted>
  <last_update_submitted>September 6, 2018</last_update_submitted>
  <last_update_submitted_qc>September 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Snoring</keyword>
  <keyword>snoreplasy</keyword>
  <keyword>Tranquill</keyword>
  <keyword>Sutures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Snoring</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

